oUR PIPELINE

We aim to develop three products: one for relieving marijuana withdrawal symptoms, another to detect genetic vulnerability to marijuana addiction, and a rapid saliva test kit to measure THC concentration in your system.

Spilled Bottle of Yellow Capsule Pills

LB101- Medications to Relieve Marijuana Withdrawal Symptoms

Marijuana withdrawal symptoms can be quite painful, and no one should have to endure such discomfort while trying to quit. We are currently screening drug candidates to help alleviate marijuana withdrawal symptoms.

pexels-photo-18069423-18069423.jpg

LB201- Marijuana Addiction Genetic Vulnerability Test

Several genes, including DRD2, ALDH2, OPRM1, CHRNA5, and CACNA1C, have been associated with an increased risk of addiction, affecting neurotransmitter systems and substance metabolism. LB201 is to be developed as a specific genetic vulnerability test for marijuana addiction.

gc106185ae140b2f96f1454d1f7372bb6c286f0a41ae5be41d9bd7c33e25b05e072aae66230dee31041ca9e7b282934ba37fc03057610e35bd4f0e12f5c0f0288_1280-4273068.jpg

LB301 - Rapid Saliva Test Kit to measure THC concentration

Just as no pilot should fly blind, no one should navigate the journey of quitting weed without insight. It can be encouraging to see the decrease in THC levels in your body, particularly in saliva. LB301 is an easy-to-use at-home test kit designed to measure THC concentration in your system and is currently in early development.

Developmental Stage of Our Pipeline

LB101 - Marijuana Withdrawal Relieve Drug
5%
LB201 - Marijuana Addiction Genetic Vulnerability Test
15%
LB301 - THC Concentration Saliva Test Kit
20%

Sign up to our newsletter

Stay up to date with Leaves Bio and Cannabis Use Disorder Research!

Sign up to our email newsletter to receive news on treatment options, research, meetings and events!